Cargando…
Bullous pemphigoid treated with Janus kinase inhibitor upadacitinib
Autores principales: | Nash, David, Kirchhof, Mark G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860157/ https://www.ncbi.nlm.nih.gov/pubmed/36691588 http://dx.doi.org/10.1016/j.jdcr.2022.12.006 |
Ejemplares similares
-
A case of drug-induced bullous pemphigoid secondary to immunotherapy
treated with upadacitinib: A case report
por: Gresham, Louise M, et al.
Publicado: (2023) -
Acne keloidalis nuchae in a patient with atopic dermatitis treated with Janus kinase inhibitor upadacitinib
por: Caudrelier, Nicolas, et al.
Publicado: (2023) -
Bridging to a selective Janus kinase 1 inhibitor in severe atopic dermatitis: An instructive case with upadacitinib
por: Nguyen, Jannett, et al.
Publicado: (2020) -
Janus kinase inhibitors in autoimmune bullous diseases
por: Huang, Dawei, et al.
Publicado: (2023) -
Recalcitrant infantile bullous pemphigoid successfully treated with cyclosporine
por: Bar-Ilan, Efrat, et al.
Publicado: (2022)